IceCure adds Legacy Health as US site for ProSense breast cancer study

IceCure added Legacy Health in Portland as a U.S. site for its ChoICE post-market study of ProSense cryoablation in low-risk breast cancer. Results have not been presented; the study is ongoing and will generate additional real-world evidence on safety and effectiveness.